Literature DB >> 19273583

Why schizophrenia epidemiology needs neurobiology--and vice versa.

John J McGrath1, Linda J Richards.   

Abstract

Schizophrenia epidemiology can provide us with valuable information to guide research directions. However, while epidemiology is useful for generating candidate risk factors, it can not always deliver studies that prove causality. We argue that the field needs more translational research that links schizophrenia epidemiology with molecular, cellular, and behavioral neuroscience. Cross-disciplinary projects related to candidate genetic or nongenetic risk factors not only can address the biological plausibility of these factors, but they can serve as catalysts for discovery in neuroscience. This type of cross disciplinary research is likely to be more efficient compared to clinically dislocated basic neuroscience. Examples of this type of translational research are provided based on (a) the impact of prenatal nutrition and prenatal infection on brain development and (b) understanding the causes and consequences of agenesis of the corpus callosum. We need to build shared discovery platforms that encourage greater cross-fertilization between schizophrenia epidemiology and basic neuroscience research.

Entities:  

Mesh:

Year:  2009        PMID: 19273583      PMCID: PMC2669581          DOI: 10.1093/schbul/sbp004

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  52 in total

1.  Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness.

Authors:  Paul H Patterson
Journal:  Curr Opin Neurobiol       Date:  2002-02       Impact factor: 6.627

2.  Vitamin D: the neglected neurosteroid?

Authors:  J McGrath; F Feron; D Eyles; A Mackay-Sim
Journal:  Trends Neurosci       Date:  2001-10       Impact factor: 13.837

3.  Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging.

Authors:  Jiangyang Zhang; Linda J Richards; Paul Yarowsky; Hao Huang; Peter C M van Zijl; Susumu Mori
Journal:  Neuroimage       Date:  2003-11       Impact factor: 6.556

4.  Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera.

Authors:  John McGrath; Darryl Eyles; Bryan Mowry; Robert Yolken; Stephen Buka
Journal:  Schizophr Res       Date:  2003-09-01       Impact factor: 4.939

5.  Cost-effectiveness of current and optimal treatment for schizophrenia.

Authors:  Gavin Andrews; Kristy Sanderson; Justine Corry; Cathy Issakidis; Helen Lapsley
Journal:  Br J Psychiatry       Date:  2003-11       Impact factor: 9.319

Review 6.  Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia?

Authors:  J McGrath
Journal:  Schizophr Res       Date:  1999-12-21       Impact factor: 4.939

Review 7.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

8.  Vitamin D3 and brain development.

Authors:  D Eyles; J Brown; A Mackay-Sim; J McGrath; F Feron
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T/+ tf/tf has severely reduced hippocampal commissure and absent corpus callosum.

Authors:  Douglas Wahlsten; Pamela Metten; John C Crabbe
Journal:  Brain Res       Date:  2003-05-02       Impact factor: 3.252

10.  Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study.

Authors:  John McGrath; Kaisa Saari; Helinä Hakko; Jari Jokelainen; Peter Jones; Marjo-Riitta Järvelin; David Chant; Matti Isohanni
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  7 in total

Review 1.  Developmental vitamin D deficiency and risk of schizophrenia: a 10-year update.

Authors:  John J McGrath; Thomas H Burne; François Féron; Allan Mackay-Sim; Darryl W Eyles
Journal:  Schizophr Bull       Date:  2010-09-10       Impact factor: 9.306

2.  Advanced paternal and grandpaternal age and schizophrenia: a three-generation perspective.

Authors:  Emma M Frans; John J McGrath; Sven Sandin; Paul Lichtenstein; Abraham Reichenberg; Niklas Långström; Christina M Hultman
Journal:  Schizophr Res       Date:  2011-10-14       Impact factor: 4.939

Review 3.  [Social psychiatry and neurobiology : A long overdue convergence exemplified by schizophrenia].

Authors:  W Kawohl; C Wyss; P Roser; M Brüne; W Rössler; G Juckel
Journal:  Nervenarzt       Date:  2017-05       Impact factor: 1.214

Review 4.  Translational epidemiology in psychiatry: linking population to clinical and basic sciences.

Authors:  Myrna M Weissman; Alan S Brown; Ardesheer Talati
Journal:  Arch Gen Psychiatry       Date:  2011-06

5.  Translating the epidemiology of psychosis into public mental health: evidence, challenges and future prospects.

Authors:  James Kirkbride; Jeremy W Coid; Craig Morgan; Paul Fearon; Paola Dazzan; Min Yang; Tuhina Lloyd; Glynn L Harrison; Robin M Murray; Peter B Jones
Journal:  J Public Ment Health       Date:  2010-06

6.  Transient activation of dopaminergic neurons during development modulates visual responsiveness, locomotion and brain activity in a dopamine ontogeny model of schizophrenia.

Authors:  B Calcagno; D Eyles; B van Alphen; B van Swinderen
Journal:  Transl Psychiatry       Date:  2013-01-08       Impact factor: 6.222

7.  A case of corpus callosum agenesis presenting with recurrent brief depression.

Authors:  Ranjan Bhattacharyya; Debasish Sanyal; Suddhendu Chakraborty; Sumita Bhattacharyya
Journal:  Indian J Psychol Med       Date:  2009-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.